For hematological malignancies, dysfunction of WT1-MEG3 signaling promotes leukemogenesis via p53-dependent and p53-independent pathways45, whereas Fas-antisense 1 lncRNA are negative regulatory factors for Fas46. This evidence concerns the gene MEG3 and hematologic disorder.